Report cover image

Global Inhaled Antibiotics Market Size & Share to 2027

Publisher QualiKet Research
Published Apr 29, 2022
Length 165 Pages
SKU # QUA17148449

Description

Global Inhaled Antibiotics Market Size & Share to 2027

Global Inhaled Antibiotics Market Size, Trends & Growth Opportunity, By Product Type (Aerosol, Dry Powder Formulation, and Spray), By Application (Pneumonia, Asthma, Bronchitis, and Others), By Distribution Channel, By Region and Forecast till 2027

Global Inhaled Antibiotics Market

Inhaled antibiotics are used to respiratory tract infections. Patients are suffering from chronic respiratory diseases like cystic fibrosis (CF) and non-CF bronchiectasis may be affected complex infections, by Methicillin-resistant Staphylococcus aureus, and by Pseudomonas aeruginosa. Inhaled antibiotics have several advantages such as it can deliver high concentrations drug at place of infection without the systematic unfavorable effects. The main application of inhaled antibiotics is to enhance drug delivery to the target site of infection.

Market Drivers

The rise in incidences of respiratory diseases such as asthma, COPD (Chronic obstructive pulmonary diseases), and bronchitis is expected to propel the global inhaled antibiotics market growth. For instance, as per the WHO report, 2020 asthma is common disease among children across the world and around 339 million people are suffering from asthma in 2016. Furthermore, as per the WHO data around 251 million cases of COPD were registered globally in 2016. Moreover,, rise in product launch activities as well as new product approvals will propel the global inhaled antibiotics market growth. For instance, in October 2017, Polyphor had launched an inhaled antibiotic murepavadin. It is type of outer membrane protein targeting antibiotic. It is specifically acts against the bacterial strain Pseudomonas aeruginosa. In addition to that, in February 2016 Teva Canada Limited had received approval from Health Canada for its generic solution called as PrTeva-Tobramycin Inhalation Solution. This solution used for the treatment of cystic fibrosis.

Market Restraints

The side effects associated with drug inhalation and unattainability of single effective inhaler are some restraining factors which are expected to limit the global inhaled antibiotics market growth. Cough, wheezing, hemoptysis and dyspnea are most common side effects caused by inhaled antibiotics.

Market Segmentation

Global Inhaled Antibiotics Market is segmented into product type Aerosol, Dry Powder Formulation, and Spray, by application such as Pneumonia, Asthma, Bronchitis, and Others. Further, market is segmented into distribution channel such as Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies.

Also, Global Inhaled Antibiotics Market is segmented five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are listed in this report such as Lupin Ltd, Polyphor, Aradigm, Gilead Sciences, Insmed Incorporated, Pharmaero, Joincare Pharmaceutical Group, Savara Pharmaceuticals,and Pharmaxis Ltd

Market Taxonomy

By Product Type
  • Aerosol
  • Dry Powder Formulation
  • Spray
By Application
  • Pneumonia
  • Asthma
  • Bronchitis
  • Others
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Inhaled Antibiotics Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Table of Contents

165 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Inhaled Antibiotics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Inhaled Antibiotics Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Inhaled Antibiotics Market Share Analysis, By Product Type
5.3 Global Inhaled Antibiotics Market Size and Forecast, By Product Type
5.3.1 Aerosol
5.3.2 Dry Powder Formulation
5.3.3 Spray
6 Global Inhaled Antibiotics Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Inhaled Antibiotics Market Share Analysis, By Application
6.3 Global Inhaled Antibiotics Market Size and Forecast, By Application
6.3.1 Pneumonia
6.3.2 Asthma
6.3.3 Bronchitis
6.3.4 Others
7 Global Inhaled Antibiotics Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Inhaled Antibiotics Market Share Analysis, By Distribution Channel
7.3 Global Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
7.3.1 Retail Pharmacies
7.3.2 Hospital Pharmacies
7.3.3 Online Pharmacies
8 Global Inhaled Antibiotics Market, By Region
8.1 Global Inhaled Antibiotics Market Share Analysis, By Region
8.2 Global Inhaled Antibiotics Market Share Analysis, By Region
8.3 Global Inhaled Antibiotics Market Size and Forecast, By Region
9 North America Inhaled Antibiotics Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Inhaled Antibiotics Market Share Analysis, By Product Type
9.3 North America Inhaled Antibiotics Market Size and Forecast, By Application
9.4 North America Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
9.5 North America Inhaled Antibiotics Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeInhaled Antibiotics Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Inhaled Antibiotics Market Share Analysis, By Product Type
10.3 Europe Inhaled Antibiotics Market Size and Forecast, By Application
10.4 Europe Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
10.5 Europe Inhaled Antibiotics Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Inhaled Antibiotics Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Inhaled Antibiotics Market Share Analysis, By Product Type
11.3 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Application
11.4 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Inhaled Antibiotics Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Inhaled Antibiotics Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Inhaled Antibiotics Market Share Analysis, By Product Type
12.3 Latin America Inhaled Antibiotics Market Size and Forecast, By Application
12.4 Latin America Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
12.5 Latin America Inhaled Antibiotics Market Size and Forecast, Country
13 Middle East Inhaled Antibiotics Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Inhaled Antibiotics Market Share Analysis, By Product Type
13.3 Middle East Inhaled Antibiotics Market Size and Forecast, By Application
13.4 Middle East Inhaled Antibiotics Market Size and Forecast, By Distribution Channel
13.5 Middle East Inhaled Antibiotics Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Lupin Ltd
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2.Polyphor
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Aradigm
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Gilead Sciences
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Insmed Incorporated
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Pharmaero
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Joincare Pharmaceutical Group
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Savara Pharmaceuticals
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Pharmaxis Ltd
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us